Risk-Benefit Assessment of Concurrent Slow Dose of Mitoxantrone to Control Active Multiple Sclerosis Under Interferon Beta-1A: an Exploratory Study

AuthID
P-003-WR7
9
Author(s)
Fernandez, O
·
Arroyo, R
·
Coret, F
·
Izquierdo, G
·
Munoz, D
·
Rodriguez Antigueedad, A
·
de Sa, JC
·
Pedrosa, R
1
Group Author(s)
Iberian Collaborative Grp
Document Type
Abstract
Year published
2008
Published
in MULTIPLE SCLEROSIS, ISSN: 1352-4585
Volume: 14, Pages: S40-S41 (2)
Conference
13Th Annual Meeting of the Amer-Comm-For-Treatment-And-Res-In-Multiple-Sclerosis/24Th Congress of the European-Comm-For-Treatment-And-Res-In-Multiple-Sclerosis/5Th Congress of the Latin-Amer-Comm-For-Treatment-And-Res-In-Multiple-Sclerosis, Date: SEP 17-20, 2008, Location: Montreal, CANADA, Sponsors: Amer Comm Treatment & Res Multiple Scleros, European Comm Treatment & Res Multiple Scleros, Latin Amer Comm Treatment & Res Multiple Scleros
Indexing
Publication Identifiers
Wos: WOS:000259675700118
Source Identifiers
ISSN: 1352-4585
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.